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OVERVIEW
Uniparental disomy represents a departure from the usual
situation in which one member of each pair of chromosomes
(calledhomologouschromosomes)isnormallyinheritedfrom
each parent. Thus, for each of the 23 pairs of human chromo-
somes,oneisnormallyinheritedfromthefatherandtheother
from the mother. Uniparental disomy (UPD) is the abnormal
situation in which both members of a chromosome pair are
inherited from one parent, and the other parent’s chromo-
some for that pair is missing.1 Uniparental disomy for some
chromosomes is without consequence, but for a few chromo-
somes can result in abnormality in the affected individual
through parent-of-origin differences in gene expression. Seri-
ousconditions,includingsyndromesaffectinggrowthandde-
velopment, can be the result. Below is an explanation of the
mechanismsandconsequencesofUPDandrecommendations
for situations in which testing for UPD is indicated.
Mechanisms causing UPD
UPDarisesusuallyfromthefailureofthetwomembersofa
chromosome pair to separate properly into two daughter cells
duringmeiosisintheparent’sgermline(nondisjunction).The
resulting abnormal gametes contain either two copies of a
chromosome (disomic) or no copy of that chromosome (nul-
lisomic), instead of the normal single copy of each chromo-
some (haploid). This leads to a conception with either three
copiesofonechromosome(trisomy)orasinglecopyofachro-
mosome (monosomy). If a second event occurs by either the
loss of one of the extra chromosomes in a trisomy or the du-
plicationofthesinglechromosomeinamonosomy,thekaryo-
typically normal cell may have a growth advantage as com-
paredtotheaneuploidcells.UPDresultsprimarilyfromoneof
these“rescue”events2(Fig.1).Othermechanismscanalsolead
toUPD,includingapostfertilizationerror(viasomaticrecom-
bination or gene conversion), gametic complementation, and
somatic replacement of a derivative chromosome.3,4 These
mechanisms, with the exception of a postfertilization error,
will result in UPD of the entire chromosome (holochromo-
somic). Since the majority of nondisjunction occurs in mater-
nal meiosis I,5 it is more likely for a trisomy to consist of two
maternalchromosomesandonepaternalchromosome.Inthis
case, maternal UPD will result if the paternal chromosome is
lost and the two maternal homologues are retained (Fig. 1a).
Therefore, in a trisomy rescue, the ensuing UPD will most
often result in heterodisomy (inheritance of the two different
homologous chromosomes from one parent). Regions of iso-
disomy (homozygosity of contiguous loci) may result from
meioticrecombination.TrisomyassociatedwithRobertsonian
translocations may also resolve to disomy through loss of a
chromosome and would result in UPD in 50% of cases (Fig.
2a). The relatively rarer monosomy rescue through duplica-
tion of a chromosome during mitosis results in isodisomy for
the whole chromosome (two identical homologues). Since
most nondisjunction events occur during maternal meiosis I,
rescue of a monosomic conceptus through chromosomal du-
plication (or isochromosome formation, see below) would be
expected to result most often in paternal UPD (Figs. 1b and
2b).
Situations associated with UPD
Of the 47 possible types of whole chromosome UPD (ma-
ternal and paternal for the 22 autosomes and X, and paternal
XY),mosthavebeenobserved(Fig.3).CasesofUPDhavebeen
identified following (a) the observation of prenatal or postna-
talmosaicism(i.e.,amixtureoftrisomicandnormalcells),(b)
identificationofastructurallyabnormalchromosome,(c)mo-
lecularinvestigationofrecessivegeneticdisease,and(d)aphe-
notypesuggestiveofaparticularsyndromeassociatedwithim-
printing.Evidenceforthetrisomyrescuemechanismhascome
in part from observations of cases of prenatal mosaicism.6,7
Discrepancies between karyotypes derived from chorionic vil-
lussamples(CVS)andthosederivedfromamnioticfluidspec-
imenshaveledtotheidentificationoftheparentaloriginofthe
chromosomes involved in the mosaicism and has uncovered
UPD in some cases.2 The observation of an abnormal karyo-
type (aneuploidy) in the placenta at CVS or pathologic exam
with a normal fetal karyotype in the amniotic fluid (termed
confined placental mosaicism) is now recognized as a risk fac-
tor for UPD.
UPD was first identified in humans when a child was found
to have cystic fibrosis (CF) due to inheritance of two identical
copies of chromosome 7 from only the mother and no contri-
bution from the father. Thus, the child’s CF was due to the
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206 Genetics IN Medicinepresence of two copies of the maternal chromosome 7 that
carried the abnormal CF gene as a result of maternal UPD for
chromosome 7.3 This situation has subsequently been identi-
fied for a number of other disorders on several chromosomes.
UPD has also been observed to result from the presence of a
structurally abnormal chromosome, including Robertsonian
translocations, isochromosomes, reciprocal translocations,
derivative chromosomes, inversions, and marker chromo-
somes. Robertsonian translocations and isochromosomes of
theacrocentricchromosomesarethemostcommonstructural
anomalies found in cases of UPD.8 This is likely due to the
increased risk for aneuploidy in offspring of Robertsonian
translocationcarriersandthemechanismsassociatedwithiso-
chromosome formation8 (Fig. 2).
In many of the UPD cases identified following investigation
of single gene disorders by linkage or mutation analyses, the
patients did not manifest additional anomalies beyond those
expected for their disease.2,4,9 However, for a few chromo-
somes, patients exhibit phenotypic effects due to genomic im-
printing.Genomicimprintingisthedifferentialexpressionofa
gene(s) depending on the sex of the transmitting parent.
Genomic imprinting is thought to occur for a relatively small
number of genes in the human genome (Fig. 3). Thus, some
genes (e.g., Prader-Willi syndrome on chromosome 15) are
expressed only from the paternally inherited chromosome;
whereas other genes (e.g., Angelman syndrome on chromo-
some 15) are expressed only from the maternally inherited
chromosome. Phenotypic abnormalities can result from over-
expression of genes in some cases (e.g., Beckwith-Wiedemann
syndrome) or lack of gene expression in other cases (e.g.,
UBE3A and Angelman syndrome). Segments of isodisomy are
ofadditionalclinicalsignificance,beyondthepossibilityofim-
printed regions, if they contain a recessive disease allele.10
Consequences of UPD
Forthemajorityofchromosomes,thereisnoapparentphe-
notypic effect from UPD (Fig. 3). However, for a few chromo-
somes, parent-specific imprinting exists and UPD of these
chromosomes lead to clinically recognizable consequences
(Fig. 3). Only five chromosomes have been shown to have a
definitephenotypiceffectduetouniparentalinheritanceofim-
printed regions (maternally derived chromosomes 7, 14, and
15; paternally derived chromosomes 6, 11, 14 and 15).2,4,9 For
some chromosomes, it is currently unclear if there are pheno-
typic effects due to imprinting (maternally derived chromo-
somes 2 and 16 and 20; paternally derived chromosome 20).
This uncertainty is due mainly to the subtle nature of the
anomalies(e.g.,maternaldisomy16),conflictingreportsinthe
literature(e.g.,inmaternaldisomy2),confoundingmosaicism
(e.g., maternal disomy 2 and 16), or too few cases reported
(e.g., maternal and paternal disomy 20).
Risks for UPD
TheempiricrisksforUPDfollowingtheobservationofpre-
natalmosaicismforcertainchromosomesoraprenatallydiag-
nosed Robertsonian translocation have been recently defined.
The chance that trisomy 15 mosaicism, observed prenatally as
confinedplacentalmosaicismonanalysisofCVS,wouldresult
in UPD has been estimated to be 11% to 25%.11–13 For prena-
tally identified Robertsonian translocations between nonho-
mologous chromosomes (e.g., rob(13q14q)), the risk of UPD
in the translocation carrier fetus is approximately 0.6%.8 For
homologousacrocentricrearrangements,forwhichthemajor-
ity are isochromosomes (i.e., chromosomes derived from a
duplicationofasingleparentalchromosome),theriskofUPD
in the balanced carrier fetus is approximately 66%.8
Given these empiric risk figures, clinicians and genetic
counselorswouldbenefitgreatlyfromguidelinesregardingdi-
agnostic testing and counseling. The following are the recom-
mendations of an American College of Medical Genetics
(ACMG) Working Group, which was convened to aid obste-
tricians, clinical geneticists, cytogeneticists, and genetic coun-
selorsinmakingdecisionsregardinguniparentaldisomydiag-
nostic testing. The document addresses diagnostic testing
recommendations for identifying UPD of the entire chromo-
Fig. 1 Common mechanisms resulting in uniparental disomy. (a) Trisomy rescue
mechanism.LossofonehomologueinatrisomyconceptustheoreticallyresultsinUPDin
one-third of cases. The example shown is that of a trisomy 15 conceptus, through which
rescue may result in maternal heterodisomy 15 and Prader-Willi syndrome. (b) Mono-
somy rescue mechanism. Duplication of the only copy of that chromosome in a mono-
somic conceptus will result in UPD. The example shown is that of a monosomy 15 con-
ceptus in which rescue would result in paternal isodisomy and Angelman syndrome.
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UPD, or UPD restricted to certain tissues, is not addressed
specifically in this document.
ASHG/ACMGrecommendationsfordiagnostictestingspe-
cific for Prader-Willi and Angelman syndromes have been
published previously,14 indicating the validity of methylation
assays for confirming or excluding the diagnosis of Prader-
Willi syndrome and Angelman syndrome. Furthermore, the
document discussed various approaches to the use of cytoge-
netic analysis, fluorescence in situ hybridization (FISH) test-
ing, methylation analysis, and UPD testing to distinguish the
specific mechanisms involved in these disorders. The current
document addresses the technical issues for UPD testing of
whole chromosomes and can be applied to the situation of
Prader-Willi syndrome and Angelman syndrome diagnostic
testing.
RECOMMENDATIONS FOR TESTING
Testing methodology
DNA-based, polymorphic markers should be utilized when
investigating UPD. Short tandem repeat markers (e.g., CA-
repeats) are used for most UPD studies. These markers are
abundant throughout the genome; many have very high het-
erozygosity values (a reflection of the allele frequency differ-
ences in the population) and are ideally suited for multiplex
PCR, allowing for 2–4 loci to be tested simultaneously.4,15,16
Parentalbloodsamplesmustbecollectedandtestedalongwith
thefetalorchild’ssample.ThePCRassaycanbeperformedon
extracted DNA or cell lysates of uncultured CVS, amniotic
fluid, or blood specimens. Multiple markers should be tested
foreachchromosomeofinterest.TheCommitteestronglyrec-
ommends that at least two fully informative loci, showing ei-
ther UPD or biparental inheritance, should be obtained for
diagnosticreporting.Foratleasttwoloci,UPDisevidentwhen
achildfailstoinheritanallelefromoneparentforonespecific
chromosome, but shows biparental inheritance for all other
chromosomes investigated. Multiple loci on a single chromo-
some will distinguish UPD from deletion. For patients show-
ing UPD, at least one other chromosome should be tested to
demonstrate biparental inheritance and consistency with cor-
Fig. 2 Common mechanisms resulting in uniparental disomy involving acrocentric
chromosomalrearrangements.(a)TrisomyrescueofatrisomyconceptusfromaRobert-
sonian translocation carrier results theoretically in UPD in 50% of cases. Since the non-
disjunction must occur in meiosis I, the resulting UPD would be heterodisomic. (b)
Monosomy rescue of a monosomic conceptus resulting from meiosis I nondisjunction
and fertilization of a nullisomic gamete. Duplication (through isochromosome forma-
tion) of the only copy of a homologue would result in isodisomy in 100% of cases. Since
the majority of nondisjunction occurs in maternal meiosis, most cases of isochromo-
somes arising through this mechanism would result in paternal isodisomy.
Fig. 3 Schematic representation of UPD cases reported in the literature. Solid black
indicates chromosomes in which UPD has not been described. Solid, dark pink or dark
blue indicate chromosomes in which maternal or paternal UPD has been described,
respectively, and an abnormal phenotype due to imprinting has been established. Solid
light pink or light blue indicate chromosomes in which maternal or paternal UPD has
beendescribed,respectively,andanabnormalphenotypeduetoimprintinghasnotbeen
clearly defined. Hatched pink or blue indicates chromosomes in which maternal or pa-
ternal UPD has been described, respectively, and no abnormal phenotype has been iden-
tified that could be attributed to imprinting. (Adapted, by permission of Oxford Univer-
sity Press, from Ledbetter and Engel, 1995.2)
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nonpaternity, this possibility should be discussed with the
family as part of the informed consent for testing. Diagnostic
reportingshouldfollowtheISCN1995guidelines:uniparental
disomy is abbreviated upd (lowercase), followed by the chro-
mosome in parentheses, and then the parental origin [e.g.,
upd(15)mat].17
There are limitations to this technology in the detection of
UPDinsampleswithsomaticmosaicism,segmentalUPD,and
tissue-specific UPD. The insufficient experience and data in
thesesituationsdonotallowforspecificrecommendationsfor
testing at this time.
Chromosomes of clinical relevance
Onanychromosome,twocopiesofadeleterioussinglegene
for a recessive disorder, through segmental isodisomy, can re-
sult in an affected child when only one parent is a carrier.
Although this can occur for any recessive allele, currently, it is
impossible to identify individuals at risk for this rare event in
advance, and these individuals may only be identified if muta-
tion or linkage analyses are being performed or if the individ-
ual also has features of a disorder caused by imprinting. Of all
possibilities, UPD for only a few chromosomes results in ab-
normalphenotypesshowntobe,orpresumedtobe,causedby
imprinting. These include maternal disomy for chromosomes
7, 14, and 15 and paternal disomy for chromosomes 6, 11, 14
and 15.
upd(6)pat and transient neonatal diabetes mellitus
Transient neonatal diabetes mellitus (DMTN, MIM
601410) is a rare form of diabetes (1 in 400,000 to 1 in 500,000
newborns) that usually resolves by 6 months of life.18,19 Al-
though the etiology is unclear in the majority of cases, a few
cases have been reported to have duplications in the long arm
of chromosome 618,20 and perhaps about 20% of cases of
DMTNhavepaternalUPD6.19Thefindingofmacroglossiaor
other anomalies in addition to DMTN is a strong indicator to
look for UPD.21 Recently, a gene involved in cell cycle control,
ZAC/PLAGL1, was identified to be imprinted and a good can-
didate for DMTN.22
upd(7)mat and Russell-Silver syndrome
The syndrome, which is now known as Russell-Silver syn-
drome (RSS, MIM 180860), was independently described by
Silver et al.23 and Russell.24 RSS is associated with prenatal and
postnatal growth retardation with relative sparing of the head,
triangular facies and other dysmorphic features, and some-
times limb and facial asymmetry. The molecular etiology for
RSSisunclearinthemajorityofcases.However,about10%of
patients with RSS have maternal disomy 7.25–28 Further evi-
dence for imprinting on chromosome 7 causing RSS comes
fromthereportoftwocasesofRSSwhohadduplicationsinthe
proximal short arm of chromosome 7.29,30 Both duplications
included the imprinted gene GRB10, which is thought to be
involved in the regulation of growth. Recently, mutations in
GRB10 in two patients with RSS lend support for this gene in
the pathogenesis of RSS.31
upd(11)pat and Beckwith-Wiedemann syndrome
Beckwith-Wiedemannsyndrome(BWS,MIM130650)isan
overgrowth syndrome associated with macroglossia, organo-
megaly,omphalocele,andothermalformationsthathasapre-
disposition to several embryonal tumors, including Wilms tu-
mor.32 Neonatal hypoglycemia is common. About 85% of
BWS cases are sporadic, but familial cases have been reported
with or without associated chromosomal aberrations involv-
ing the most distal band on the short arm of chromosome 11.
In chromosomally abnormal cases that produce a partial tri-
somyfor11p15.5,ithasbeendeterminedthattheoriginofthe
duplicatedsegmentispaternal,wheninvestigated.Incontrast,
somecaseshavebeenreportedwithapparentlybalancedtrans-
locations or inversions involving 11p15, and in all cases the
abnormality was inherited from the mother.33 Partial paternal
UPD for the distal short arm of chromosome 11 occurs in
about 20% of BWS patients.34–36 Different from the whole
chromosome UPD for chromosome 15 that is observed in
Prader-Willi syndrome and Angelman syndrome, the UPD in
BWS is isodisomic and usually confined to the 11p15 region.
Additionally, mosaicism has been demonstrated at the single
cell level.37 This indicates that the UPD in BWS is a somatic
event rather than a meiotic nondisjunction event. For the re-
maining patients not demonstrating a chromosome abnor-
mality or UPD, a few demonstrate biallelic expression of the
paternally expressed insulin-like growth factor II (IGF2),38 a
small number of patients have mutations in the cyclin-depen-
dent kinase inhibitor 1C (p57
KIP2) gene,39 and the majority of
patientsshowlossofimprintingforthelongQTintronictran-
script 1 (LIT1) gene.40
upd(14)mat
Individualswithmaternaldisomy14haveshortstature,hy-
potonia,hyperextensiblejoints,scoliosis,minorfacialdysmor-
phic features, mild developmental delay, and precocious pu-
berty.41 Maternal UPD 14 has been reported in association
withmosaicism,Robertsoniantranslocations,andisochromo-
somes.2,4,9 One patient with a partial maternal UPD for chro-
mosomal segments 14q23–14q24.2 who showed developmen-
tal delay, mild dysmorphic features, and joint laxity may help
to narrow the region in which to search for imprinted genes.42
upd(14)pat
Individualswithpaternaldisomy14haveamoreseverephe-
notype than those with maternal disomy 14, including mental
retardation, skeletal abnormalities that result in short-limb
dwarfism with narrow thorax, decreased survival due to respi-
ratory difficulties, dysmorphic facies, and scoliosis.41 Patients
with paternal disomy 14 have been diagnosed following iden-
tification of Robertsonian translocations or isochromosomes
involving chromosome 14.
Diagnostic testing for uniparental disomy
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Prader-Willi syndrome (PWS, MIM 176270) is character-
ized by neonatal hypotonia and poor suck with failure to
thrive, developmental delay and/or mental retardation, child-
hood-onset obesity, short stature, hypogonadism, and severe
behavior problems. About 70% of patients with PWS have a
deletionofband15q12onthepaternallyderivedchromosome.
About 28% of cases of PWS result from maternal disomy for
chromosome 15 and about 2% have a defect in the imprinting
process.14 There are a number of imprinted genes in the PWS
critical region, but it is currently not known which of these
contribute to the PWS phenotype.43
upd(15)pat and Angelman syndrome
Angelman syndrome (AS, MIM 234400) is associated with
severe mental retardation with absent speech, ataxic move-
ments and gait, increased tone after infancy, seizures, and a
happy disposition with paroxysmal laughter. About 70% of
patients with AS have a deletion of chromosome band 15q12
onthematernallyinheritedchromosome,3–5%ofcasesofAS
resultfromupd(15)pat,14about5%ofpatientshavemutations
in the ubiquitin-protein ligase E3A (UBE3A) gene, about 3%
have abnormal imprinting by methylation analysis, and the
remaining patients (10–14%) have no identifiable molecular
defect.44
Individuals in whom testing should be considered
c Fetuses with complete trisomy, level II (trisomy in more
than one cell in a single primary culture) or level III (tri-
somy in more than one cell in multiple independent cul-
tures)mosaicismonCVSforchromosomes6,7,11,14,or
15.
c Fetuses with level II mosaicism on amniotic fluid chro-
mosomes for chromosomes 6, 7, 11, 14, or 15.
c Fetuses found to carry a Robertsonian translocation or
possible isochromosome involving chromosomes 14 or
15. Both familial Robertsonian translocations and de
novo translocations are considered to be at risk for UPD.
c Fetuses with anomalies identified by ultrasound that are
consistent with features found in UPD syndromes, with
or without a structural chromosome abnormality affect-
ing the relevant chromosome.
c Infants or children who present with multiple congenital
anomalies, developmental delay or mental retardation,
and carry a Robertsonian translocation involving chro-
mosomes 14 or 15.
c Newborns or infants presenting with neonatal diabetes
mellitus.
c Infants or children with features of Russell-Silver
syndrome.
c Infants suspected to have Beckwith-Wiedemann syn-
drome with normal karyotypes and no duplication of
11p15.5 by fluorescence in situ hybridization (FISH).
c Patients with features of Prader-Willi syndrome or An-
gelman syndrome who have an abnormal methylation
pattern.14
SUMMARY OF CLINICAL AND DIAGNOSTIC
CONSIDERATIONS
1. Chromosomes of known clinical relevance include 6, 7, 11,
14, and 15.
2. UPD testing should be considered for
(a) patientspresentingwithprenatallydetectedmosaicism
or Robertsonian translocations for clinically relevant
chromosomes.
(b) patientspresentingwithfeaturesofdisordersknownto
be associated with UPD.
3. Testing should be performed on DNA collected from the
mother,father,andchild/fetususingpolymorphicmarkers.
4. Reporting of results includes at least two fully informative
markers from each chromosome of interest and reported
using the ISCN 1995 guidelines.17
Approved by the Board of Directors of the American College of
Medical Genetics on January 21, 2001.
q AMERICAN COLLEGE OF MEDICAL GENETICS, 2001
Acknowledgments
The authors thank Robert L. Nussbaum (representing the
oversightcommittee),NationalInstitutesofHealth,Bethesda,
andJonathanZonana(representingtheoversightcommittee),
Oregon Health Sciences University, Portland, for their guid-
ance; and Bassem Bejjani, Baylor College of Medicine, for his
critical review of the manuscript.
References
1. Engel E. A new genetic concept: uniparental disomy and its potential effect, isodis-
omy. Am J Med Genet 1980;6:137–143.
2. LedbetterDH,EngelE.Uniparentaldisomyinhumans:developmentofanimprint-
ing map and its implications for prenatal diagnosis. Hum Mol Genet 1995;4:1757–
1764.
3. Spence JE, Perciaccante RG, Greig GM, Willard HF, Ledbetter DH, Hejtmancik JF,
Pollack MS, O’Brien WE, Beaudet AL. Uniparental disomy as a mechanism for
human genetic disease. Am J Hum Genet 1988;42:217–226.
4. Shaffer LG, McCaskill C, Adkins K, Hassold TJ. Systematic search for uniparental
disomyinearlyfetallosses:theresultsandareviewoftheliterature.AmJMedGenet
1998;79:366–372.
5. KoehlerKE,HawleyRS,ShermanS,HassoldT.Recombinationandnondisjunction
in humans and flies. Hum Mol Genet 1996;5:1495–1504.
6. Cassidy SB, Lai LW, Erickson RP, Magnuson L, Thomas E, Gendrom R, Herrmann
J.Trisomy15withlossofthepaternal15asacauseofPrader-Willisyndromedueto
maternal disomy. Am J Hum Genet 1992;51:701–708.
7. Kalousek DK, Langlois S, Barrett I, Yam I, Wilson DR, Howard-Peebles PN, John-
son MP, Giorgiutti E. Uniparental disomy for chromosome 16 in humans. Am J
Hum Genet 1993;52:8–16.
8. BerendSA,HorwitzJ,McCaskillC,ShafferLG.Identificationofuniparentaldisomy
following prenatal detection of Robertsonian translocations and isochromosomes.
Am J Hum Genet 2000;66:1787–1793.
9. Kotzot D. Abnormal phenotypes in uniparental disomy (UPD): fundamental as-
pectsandacriticalreviewwithbibliographyofUPDotherthan15.AmJMedGenet
1999;82:265–274.
10. Engel E, DeLozier-Blanchet CD. Uniparental disomy, isodisomy, and imprinting.
Probable effects in man and strategies for their detection. Am J Med Genet 1991;40:
432–439.
Shaffer et al.
210 Genetics IN Medicine11. RobinsonWP,LangloisS,SchuffenhauerS,HorsthemkeB,MichaelisRC,Christian
S, Ledbetter DH, Schinzel A. Cytogenetic and age-dependent risk factors associated
with uniparental disomy 15. Prenat Diagn 1996;16:837–844.
12. ChristianSL,SmithACM,MachaM,BlackSH,ElderFFB,JohnsonJM-P,RestaRG,
SurtiU,SuslakL,VerpMS,LedbetterDH.Prenataldiagnosisofuniparentaldisomy
15 following trisomy 15 mosaicism. Prenat Diagn 1996;16:323–332.
13. EuropeanCollaborativeResearchonMosaicisminCVS(EUCROMIC).Trisomy15
CPM: probable origins, pregnancy outcome and risk for fetal UPD. Prenat Diagn
1999;19:29–35.
14. CassidySB,BeaudetAL,KnollJHM,LedbetterDH,NichollsRD,SchwartzS,Butler
MG, Watson M. ASHG/ACMG report. Diagnostic testing for Prader-Willi and An-
gelman syndromes. Report of the ASHG/ACMG Test and Technology Transfer
Committee. Am J Hum Genet 1996;58:1085–1088.
15. Huang TH, Cottingham RW, Ledbetter DH, Zoghbi HY. Genetic mapping of four
dinucleotide repeat loci, DXS453, DXS458, DXS454, and DXS424, on the X chro-
mosome using multiplex polymerase chain reaction. Genomics 1992;13:375–380.
16. Shaffer LG, Overhauser J, Jackson L, Ledbetter DH. Genetic syndromes and unipa-
rental disomy: a study of 16 cases of Brachmann-de Lange Syndrome. Am J Med
Genet 1993;47:383–386.
17. Mitelman F. ISCN 1995: an international system for human cytogenetic nomencla-
ture. Karger: Basel, Switzerland p. 49.
18. Temple IK, Gardner RJ, Robinson DO, Kibirige MS, Ferguson AW, Baum JD, Bar-
ber JC, James RS, Shield JP. Further evidence for an imprinted gene for neonatal
diabetes localised to chromosome 6q22-q23. Hum Mol Genet 1996;5:1117–1121.
19. Gardner RJ, Robinson DO, Lamont L, Shield JP, Temple IK. Paternal uniparental
disomyofchromosome6andtransientneonataldiabetesmellitus.ClinGenet1998;
54:522–525.
20. Arthur EI, Zlotogora J, Lerer I, Dagan J, Marks K, Abeliovich D. Transient neonatal
diabetes mellitus in a child with inv dup(6)(q22q23) of paternal origin. Eur J Hum
Genet 1997;5:417–419.
21. ChristianSL,RichBH,LoeblC,IsraelJ,VasaR,KittikamronK,SpiroR,Rosenfield
R, Ledbetter DH. Significance of genetic testing for paternal uniparental disomy of
chromosome 6 in neonatal diabetes mellitus. J Pediatr 1999;134:42–46.
22. Kamiya M, Judson H, Okazaki Y, Kusakabe M, Muramatsu M, Takada S, Takagi N,
Arima T, Wake N, Kamimura K, Satomura K, Hermann R, Bonthron DT, Hayash-
izaki Y. The cell cycle control gene ZAC/PLAGL1 is imprinted: a strong candidate
gene for transient neonatal diabetes. Hum Mol Genet 2000;9:453–460.
23. Silver HD, Kiyasu W, George J, Deamer WC. Syndrome of congenital hemihyper-
trophy, shortness of stature, and elevated urinary gonadotrophins. Pediatrics 1953;
12:368–376.
24. Russell A. A syndrome of intrauterine dwarfism recognizable at birth with cranio-
facial dysostosis, disproportionate short arms and other anomalies. Proc R Soc Med
1954;47:1040–1044.
25. Kotzot D, Schmitt S, Bernasconi F, Robinson WP, Lurie IW, Ilyina H, Mehes K,
HamelBCJ,OttenBJ,HergersbergM,WerderE,SchoenleE,SchinzelA.Uniparen-
tal disomy 7 in Silver-Russell syndrome and primordial growth retardation. Hum
Mol Genet 1995;4:583–587.
26. PreeceMA,PriceSM,DaviesV,CloughL,StanierP,TrembathRC,MooreGE.Maternal
uniparental disomy 7 in Silver-Russell syndrome. J Med Genet 1997;34:6–9.
27. Eggermann T, Wollmann HA, Kuner R, Eggermann K, Enders H, Kaiser P, Ranke
MB. Molecular studies in 37 Silver-Russell syndrome patients: frequency and etiol-
ogy of uniparental disomy. Hum Genet 1997;100:415–419.
28. PriceSM,StanhopeR,GarrettC,PreeceMA,TrembathRC.ThespectrumofSilver-
Russellsyndrome:aclinicalandmoleculargeneticstudyandnewdiagnosticcriteria.
J Med Genet 1999;36:837–842.
29. Joyce CA, Sharp A, Walker JM, Bullman H, Temple IK. Duplication of 7p12.1-p13,
including GRB10 and IGFBP1, in a mother and daughter with features of Silver-
Russell syndrome. Hum Genet 2000;105:273–280.
30. Monk D, Wakeling EL, Proud V, Hitchins M, Abu-Amero S, Stanier P, Preece MA,
Moore GE. Duplication of 7p11.2-p13, including GRB10, in Silver-Russell syn-
drome. Am J Hum Genet 2000;66:36–46.
31. Yoshihashi H, Maeyama K, Kosaki R, Ogata T, Tsukahara M, Goto Y-I, Hata J-I,
Matsuo N, Smith RJ, Kosaki K. Imprinting of human GRB10 and its mutations in
two patients with Russell-Silver syndrome. Am J Hum Genet 2000;67:476–482.
32. Weng EY, Mortier GR, Graham JM. Beckwith-Wiedemann syndrome. An update
and review for the primary pediatrician. Clin Pediatr 1995;34:317–326.
33. Junien C. Beckwith-Wiedemann syndrome, tumourigenesis and imprinting. Curr
Opin Genet Dev 1992;2:431–438.
34. Henry I, Bonaiti-Pellie C, Chehensse V, Beldjord C, Schwartz C, Utermann C,
Junien C. Uniparental paternal disomy in a genetic cancer-predisposing syndrome.
Nature 1991;351:665–667.
35. Henry I, Puech A, Riesewijk A, Ahnine L, Mannens M, Beldjord C, Bitoun P, Tour-
nada M-F, Landrieu P, Junien C. Somatic mosaicism for partial paternal isodisomy
in Wiedemann-Beckwith syndrome: a post-fertilization event. Eur J Hum Genet
1993;1:19–29.
36. Catchpoole D, Lam WW, Valler D, Temple IK, Joyce JA, Reik W, Schofield PN,
Maher ER. Epigenetic modification and uniparental inheritance of H19 in Beck-
with-Wiedemann syndrome. J Med Genet 1997;34:353–359.
37. Bischoff FZ, Feldman GL, McCaskill C, Subramanian S, Hughes MR, Shaffer LG.
Singlecellanalysisdemonstratingsomaticmosaicisminvolving11pinapatientwith
paternal isodisomy and Beckwith-Wiedemann syndrome. Hum Mol Genet 1995;4:
395–399.
38. WeksbergR,ShenDR,FeiY-L,SongQL,SquireJ.Disruptionofinsulin-likegrowth
factor2imprintinginBeckwith-Wiedemannsyndrome.NatGenet1993;5:143–150.
39. HatadaI,OhashiH,FukushimaY,KanekoY,InoueM,KomotoY,OkadaA,Ohishi
S, Nabetani A, Morisaki H, Nakayama M, Niikawa N, Mukai T. An imprinted gene
p57
KIP2 is mutated in Beckwith-Wiedemann syndrome. Nat Genet 1996;14:171–
173.
40. Lee MP, DeBaun MR, Mitsuya K, Galonek HL, Brandenburg S, Oshimura M, Fein-
berg AP. Loss of imprinting of a paternally expressed transcript, with antisense
orientation to KVLQT1, occurs frequently in Beckwith-Wiedemann syndrome and
is independent of insulin-like growth factor II imprinting. Proc Natl Acad Sci USA
1999;96:5203–5208.
41. Sutton VR, Shaffer LG. A search for imprinted regions on chromosome 14: com-
parison of maternal and paternal UPD cases with cases of chromosome 14 deletion.
Am J Med Genet 2000;93:381–387.
42. MartinRA,SabolDW,RoganPK.Maternaluniparentaldisomyofchromosome14
confinedtoaninterstitialsegment(14q23–14q24.2).JMedGenet1999;36:633–636.
43. Nicholls RD. Incriminating gene suspects, Prader-Willi style. Nat Genet 1999;23:
132–134.
44. Jiang Y-H, Lev-Lehman E, Bressler J, Tsai T-F, Beaudet AL. Neurogenetics ’99 Ge-
netics of Angelman syndrome. Am J Hum Genet 1999;65:1–6.
This statement is designed primarily as an educational resource for medical geneticists and other health care providers to help them
provide quality medical genetic services. Adherence to this statement does not necessarily ensure a successful medical outcome. This
statement should not be considered inclusive of all proper procedures and tests or exclusive of other procedures and tests that are
reasonably directed to obtaining the same results. In determining the propriety of any specific procedure or test, the geneticist should
apply his or her own professional judgment to the specific clinical circumstances presented by the individual patient or specimen. It
may be prudent, however, to document in the patient’s record the rationale for any significant deviation from this statement.
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